Google Alert - pharmaceutical news

News 10 new results for pharmaceutical news

Why Valeant's Medicis buy is positive for shareholders Globe and Mail Most analysts are applauding the move by Valeant Pharmaceuticals International Inc. to stake its future on wrinkles and pimples. With Monday's proposed $2.6-billion (U.S.) acquisition of skincare company Medicis Pharmaceutical Corp., Valeant is poised ... See all stories on this topic » Globe and Mail

Diverse Pipeline And Multiple Catalysts Point To Opportunity At NovaBay ... Reuters NovaBay Pharmaceuticals (AMEX:NBY) is a company developing two distinct anti-infective product lines: Aganocide compounds, led by NVC-422 and NeutroPhase R , (also referred to as NVC-101). Both are designed to work by mimicking the body's natural ... See all stories on this topic »

Pharmaceutical plant to relocate after pollution scandal China Daily HARBIN - The Harbin Pharmaceutical Group, a major pharmaceutical company in Northeast China's Heilongjiang province, has decided to relocate one of its plants from downtown Harbin to the city's outskirts following a pollution scandal that occurred last ... See all stories on this topic »

India to Extend Price Controls on Drugs Wall Street Journal (India) Any attempt to restrict prices of patented drugs likely will rankle foreign pharmaceutical companies. Protecting patented products is crucial to foster innovation, so "any price control in that area will stifle [research and development] initiatives ... See all stories on this topic » Wall Street Journal (India)

SALIX PHARMACEUTICALS, LTD. : Salix Pharmaceuticals Outlines Data ... 4-traders Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that five presentations describing the investigation of methylnaltrexone bromide as a potential treatment for opioid-induced constipation in adult patients with chronic, non-cancer pain will ... See all stories on this topic »

Harwood Feffer LLP Announces Investigation of Medicis Pharmaceutical Corp. Sacramento Bee NEW YORK, Sept. 4, 2012 -- /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Medicis Pharmaceutical Corp. ("Medicis" or the "Company") (NYSE: MRX) concerning the proposed ... See all stories on this topic »

Sun Pharmaceutical Recalls One Lot of Nimodipine Capsules Pharmaceutical Processing Sun Pharmaceutical Industries, Inc. is voluntarily recalling from users one lot of Nimodipine Capsules, 30 mg, marketed by Caraco Pharmaceutical Laboratories, Ltd. Sun Inc. commenced the recall as a precautionary measure due to the presence of crystals ... See all stories on this topic »

Hi-Tech Pharmacal 1st-Quarter Net Down 56% on Nasal Spray Pricing Wall Street Journal The specialty pharmaceutical company, which focuses on generic oral liquid drugs and various topical treatments, had been seeing its sales grow for almost two years as cost-conscious consumers and pharmacy-benefit managers seek to rein in costs. See all stories on this topic »

BIOMARIN PHARMACEUTICAL INC. : BioMarin Names Jeff Ajer Senior Vice ... 4-traders 5, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jeff Ajer, the current Vice President, Commercial Operations, the Americas, will be promoted to Senior Vice President, Chief Commercial Officer. Mr. Ajer ... See all stories on this topic »

SALIX PHARMACEUTICALS, LTD. : FDA Continues Review of Crofelemer New ... 4-traders Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Food and Drug Administration has advised the Company that its New Drug Application (NDA) for crofelemer 125 mg tablets, for the proposed indication of symptomatic relief of ... See all stories on this topic »

---

Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.